Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/29930
Title: | Heterozygous PNPT1 Variants Cause Spinocerebellar Ataxia Type 25. | Austin Authors: | Barbier, Mathieu;Bahlo, Melanie;Pennisi, Alessandra;Jacoupy, Maxime;Tankard, Rick M;Ewenczyk, Claire;Davies, Kayli C;Lino-Coulon, Patricia;Colace, Claire;Rafehi, Haloom;Auger, Nicolas;Ansell, Brendan R E;van der Stelt, Ivo;Howell, Katherine B;Coutelier, Marie;Amor, David J;Mundwiller, Emeline;Guillot-Noël, Lena;Storey, Elsdon;Gardner, R J McKinlay;Wallis, Mathew J ;Brusco, Alfredo;Corti, Olga;Rötig, Agnès;Leventer, Richard J;Brice, Alexis;Delatycki, Martin B ;Stevanin, Giovanni;Lockhart, Paul J;Durr, Alexandra | Affiliation: | Clinical Genetics Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia Bruce Lefroy Centre, Murdoch Children's Research Institute, Melbourne, Victoria, Australia Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia Donders Centre for Neuroscience, Faculty of Science, Radboud University, Nijmegen, The Netherlands Department of Neurology, Royal Children's Hospital, Melbourne, Victoria, Australia Murdoch Children's Research Institute, Melbourne, Victoria, Australia Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia School of Medicine and Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia Victorian Clinical Genetics Service, Melbourne, Australia Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France Clinical Genetics Group, University of Otago, Dunedin, New Zealand Department of Medical Sciences, University of Torino, Torino, Italy Necker Hospital, APHP, Reference Center for Mitochondrial Diseases, Genetics Department, Institut Imagine, University of Paris, Paris, France School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia Inserm UMR_S1163, Institut Imagine, Paris, France Paris Sciences Lettres Research University, EPHE, Paris, France |
Issue Date: | Jul-2022 | Date: | 2022-05-07 | Publication information: | Annals of Neurology 2022; 92(1): 122-137 | Abstract: | Dominant spinocerebellar ataxias (SCA) are characterized by genetic heterogeneity. Some mapped and named loci remain without a causal gene identified. Here we applied next generation sequencing (NGS) to uncover the genetic etiology of the SCA25 locus. Whole-exome and whole-genome sequencing were performed in families linked to SCA25, including the French family in which the SCA25 locus was originally mapped. Whole exome sequence data were interrogated in a cohort of 796 ataxia patients of unknown etiology. The SCA25 phenotype spans a slowly evolving sensory and cerebellar ataxia, in most cases attributed to ganglionopathy. A pathogenic variant causing exon skipping was identified in the gene encoding Polyribonucleotide Nucleotidyltransferase PNPase 1 (PNPT1) located in the SCA25 linkage interval. A second splice variant in PNPT1 was detected in a large Australian family with a dominant ataxia also mapping to SCA25. An additional nonsense variant was detected in an unrelated individual with ataxia. Both nonsense and splice heterozygous variants result in premature stop codons, all located in the S1-domain of PNPase. In addition, an elevated type I interferon response was observed in blood from all affected heterozygous carriers tested. PNPase notably prevents the abnormal accumulation of double-stranded mtRNAs in the mitochondria and leakage into the cytoplasm, associated with triggering a type I interferon response. This study identifies PNPT1 as a new SCA gene, responsible for SCA25, and highlights biological links between alterations of mtRNA trafficking, interferonopathies and ataxia. ANN NEUROL 2022;92:122-137. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/29930 | DOI: | 10.1002/ana.26366 | ORCID: | https://orcid.org/0000-0002-5154-2163 https://orcid.org/0000-0001-5132-0774 https://orcid.org/0000-0002-4525-8633 https://orcid.org/0000-0003-1841-7747 https://orcid.org/0000-0002-8847-9401 https://orcid.org/0000-0002-8795-6501 https://orcid.org/0000-0002-2977-0282 https://orcid.org/0000-0002-8954-4930 https://orcid.org/0000-0003-0297-897X https://orcid.org/0000-0002-5469-8411 https://orcid.org/0000-0001-7191-8511 https://orcid.org/0000-0002-5441-1732 https://orcid.org/0000-0002-8318-7231 https://orcid.org/0000-0003-2093-7389 https://orcid.org/0000-0003-0589-0703 https://orcid.org/0000-0003-0362-5607 https://orcid.org/0000-0002-0941-3990 https://orcid.org/0000-0001-9368-8657 https://orcid.org/0000-0003-2531-8413 https://orcid.org/0000-0002-8921-7104 |
Journal: | Annals of Neurology | PubMed URL: | 35411967 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35411967/ | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.